Emergent BioSolutions, Inc. (EBS)
8.19
+0.11
(+1.36%)
USD |
NYSE |
Mar 20, 16:00
8.185
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Research and Development Expense (Quarterly) : 12.10M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 569.00M |
| Eli Lilly & Co. | 3.802B |
| Penumbra, Inc. | 17.52M |
| Disc Medicine, Inc. | 46.14M |
| MetaVia, Inc. | 1.914M |